Cargando…
Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis
BACKGROUND: Tumorigenesis is highly heterogeneous, and using clinicopathological signatures only is not enough to effectively distinguish clear cell renal cell carcinoma (ccRCC) and improve risk stratification of patients. DNA methylation (DNAm) with the stability and reversibility often occurs in t...
Autores principales: | Liu, Pengfei, Tian, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409785/ https://www.ncbi.nlm.nih.gov/pubmed/32832275 http://dx.doi.org/10.7717/peerj.9654 |
Ejemplares similares
-
AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019) -
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021) -
Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma
por: Zhao, Yiqiao, et al.
Publicado: (2020) -
The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study
por: Xu, Fangshi, et al.
Publicado: (2021) -
Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)